samarium has been researched along with Adenocarcinoma, Basal Cell in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, U; Turner, J | 1 |
| Douard, MC; George, B; Rain, JD | 1 |
| Antoñanzas Villar, F; Carreras Coderch, L; Coya Viña, J; Echevarría Icaza, A; Martín Comín, J; Martínez Carderón, F; Nieto Martín-Bejarano, J; Sáenz Cusí, A; Serrano Bermúdez, G; Velasco Latrás, M | 1 |
| Bushnell, D; Higano, CS; Quick, DP; Sartor, O | 1 |
| Bernà, L; Cunill, C; Javier Mateos, J; Martín, F; Nadal, C; Ortega, M; Pons, F | 1 |
| DeWeese, TL; Ramakrishna, NR; Thurman, SA | 1 |
| Atefie, K; Köck, HH; Sinzinger, H; Weiss, K | 1 |
| Bushnev, AS; Dillehay, DL; Liotta, DC; Merrill, AH; Schmelz, EM | 1 |
2 review(s) available for samarium and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
[Metabolic radiotherapy: what role will it have in 2001?].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome | 2002 |
Radiation therapy for the treatment of locally advanced and metastatic prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Brachytherapy; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Gene Deletion; Gonadotropin-Releasing Hormone; Hemibody Irradiation; Hormone Antagonists; Humans; Male; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neutrons; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Proton Therapy; Radiation Tolerance; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Samarium; Strontium Radioisotopes; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2001 |
1 trial(s) available for samarium and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
[Cost-effectiveness analysis of samario-153 (Quadramet) for the treatment of patients with prostate cancer and bone metastases].
Topics: Adenocarcinoma; Analgesics, Non-Narcotic; Bone Neoplasms; Cost-Benefit Analysis; Drug Costs; Humans; Male; Models, Economic; Organometallic Compounds; Organophosphorus Compounds; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Samarium; Treatment Outcome | 2005 |
5 other study(ies) available for samarium and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer.
Topics: Adenocarcinoma; Anilides; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Basidiomycota; Combined Modality Therapy; Drug Resistance, Neoplasm; Humans; Leuprolide; Lumbar Vertebrae; Male; Nitriles; Phytotherapy; Plant Extracts; Polysaccharides; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Remission Induction; Samarium; Self Medication; Spinal Neoplasms; Tosyl Compounds | 2009 |
Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Samarium; Survival Rate | 2008 |
[153Sm-EDTMP in a patient suffering from colon cancer with bone metastasis].
Topics: Adenocarcinoma; Adult; Beta Particles; Bone Neoplasms; Cervical Vertebrae; Gamma Rays; Humans; Male; Organophosphorus Compounds; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rectal Neoplasms; Samarium; Scapula; Skull Neoplasms; Spinal Neoplasms | 2001 |
Complete scintigraphic lesion regression after single 153Sm-EDTMP therapy in prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Samarium | 2001 |
Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Diet; Dimethylhydrazines; Female; Mice; Milk; Precancerous Conditions; Sphingolipids; Sphingomyelins; Weight Gain | 1997 |